Myriad Genetics (MYGN) Change in Inventory (2011 - 2026)

Myriad Genetics (MYGN) has 16 years of Change in Inventory data on file, last reported at -$2.7 million in Q1 2026.

• Change in Inventory for Q1 2026 came in at -$2.7 million, down 400.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$400000.0 (down 107.55% YoY), and the FY2025 annual result was $3.2 million, down 48.39% from the prior year.
• Change in Inventory fell to -$2.7 million in Q1 2026 per MYGN's latest filing, from -$900000.0 in the prior quarter.
• Over five years, Change in Inventory peaked at $4.3 million in Q3 2022 and troughed at -$3.2 million in Q4 2023.
• A 5-year average of $712500.0 and a median of $750000.0 in 2023 frame the typical range for Change in Inventory.
• The sharpest annual moves came in 2023 and 2026: Change in Inventory jumped 750.0% in 2023, then slumped 400.0% in 2026.
• A 5-year view of Change in Inventory shows it stood at -$1.5 million in 2022, then plunged by 113.33% to -$3.2 million in 2023, then soared by 140.62% to $1.3 million in 2024, then tumbled by 169.23% to -$900000.0 in 2025, then sank by 200.0% to -$2.7 million in 2026.
• Business Quant data shows MYGN's Change in Inventory at -$2.7 million in Q1 2026, -$900000.0 in Q4 2025, and $2.9 million in Q3 2025.